MedPath

7 NUTS Study. Diet Modification and Male Fertility.

Phase 2
Conditions
Teratospermia
Male Subfertility
Oligospermia
Asthenospermia
Interventions
Dietary Supplement: 7 nuts a day
Other: Diet modification
Registration Number
NCT02063256
Lead Sponsor
A.O.U. Città della Salute e della Scienza
Brief Summary

Setting. Outpatient fertility clinic.

Aim. Investigate if a modification in nutritional habits may improve in the short term the qualities of human sperm, testing two hypothesis:

i) that adding to the diet a natural whole food rich in polyunsaturated fatty acids (PUFA)

OR

ii) that reducing the intake of saturated fatty acids and increasing the consumption of PUFA may affect beneficially sperm parameters.

Population. N. 100 hypofertile male subjects attending a fertility clinic.

Type of study. Interventional study. No drugs or pharmacologic supplementation will be required nor allowed.

Two different type of intervention are scheduled:

* Supplementation to western style diet with nuts, naturally rich in PUFA

* Diet modification increasing intake of PUFA-rich foods and cutting the consumption of food rich in saturated fats.

Protocol

* Baseline visit and recruiting.

* Informed consent

* Randomized allocation to treatment group in a 1: 1 manner

Blinding. Investigators deputed to sperm analysis and statistician are blinded as to type of intervention.

Phases:

* i) basal

* ii) after 15 weeks That interval is chosen because encompasses an entire spermatogenesis cycle.

Outcomes. Primary

* sperm count, concentration,morphology and mobility.

Secondary:

* serum folate assay,

* plasma PUFA (ALA, EPA, DHA) assay,

* body weight and BMI variation

Statistics. A comparison for all sperm parameters (count,concentration,morphologic abnormalities, mobility) will be carried out by an analysis within groups and within patient.

Detailed Description

The planned trial is nutritional based only, with a modification of diet in order to obtain an increase of PUFA intake with/without a reduction of saturated fatty acid intake.

Two different types of intervention are scheduled:

* Supplementation to western style diet with food naturally rich in PUFA

* Diet modification, increasing intake of PUFA naturally rich foods and cutting the consumption of saturated fats.

The supplementation is obtained adding 7 nuts a day to regular diet. The diet modification is obtained by increasing intake of nuts and seeds (walnuts, hazelnuts, almonds, peanuts, sesame, sunflower, flaxseed) and derived oils, fish and vegetables; cutting the consumption of processed meat and dairy products is required as well.

The type of diet or supplementation is supported by oral and written information. The compliance to diet will be followed by administration of validated questionnaires.

The effect of the diet modifications will be followed by a number of plasma biomarkers we plan to compare at baseline and post intervention. The body weight and BMI will be checked, as both types of intervention are intended to not affect significantly mean body weight.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
100
Inclusion Criteria
  • sperm concentration > 5.000.000 ml
  • progressive motile forms < 35%
  • BMI < 30
  • normal FSH (Follicle Stimulating Hormone reference values 1-10 IU)
Exclusion Criteria
  • allergy to nuts or seeds
  • clinical varicocele
  • recent surgery for varicocele
  • vasectomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
7 NUTS a day7 nuts a daythe patients allocated to this arm will be instructed to supplement their diet with 7 nuts a day (whole shelled weight around 75 grams)
Diet modificationDiet modificationthe patients allocated to this arm will be instructed to modify their diet allowing more intake of PUFA rich food avoiding saturated fat rich food
Primary Outcome Measures
NameTimeMethod
sperm motility15 weeks

change in sperm motility (% of progressive forms) from baseline to 15 weeks

sperm count15 weeks

Change in sperm count from baseline to 15 weeks

sperm concentration15 weeks

change in sperm concentration from baseline to 15 weeks

sperm morphology15 weeks

change in sperm morphology ( % normal forms ) from baseline to 15 weeks

Secondary Outcome Measures
NameTimeMethod
change in weight (BMI)15 weeks

change in body weight (BMI) from baseline to 15 weeks

Change in serum cholesterol15 weeks

change in serum cholesterol levels from baseline to 15 weeks

change in serum folate15 weeks

change in serum folate from baseline to 15 weeks

change in plasma alpha linolenic acid (ALA) levels15 weeks

change in ALA levels from baseline to 15 weeks

change in plasma eicosapentaenoic acid (EPA)15 weeks

change in plasma EPA levels from baseline to 15 weeks

change in plasma docosahexaenoic acid (DHA)15 weeks

change in plasma DHA levels from baseline to 15 weeks

Trial Locations

Locations (1)

Ospedale Sant'Anna. Dipartimento di Ostetricia e Neonatologia. S.C. Biochimica Clinica "Baldi e Riberi" Settore Malattie Metaboliche - Dipartimento di Medicina di Laboratorio A.O.U. Citta' della Salute e della Scienza Presidio San Giovanni Battista - Moli

🇮🇹

Torino, Italy

© Copyright 2025. All Rights Reserved by MedPath